Loading clinical trials...
Loading clinical trials...
A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis
Conditions
Interventions
LEV102 1.0%
LEV102 2.0%
+1 more
Locations
3
United States
Eye Research Foundation
Newport Beach, California, United States
Steve Yoelin Medical Associates
Newport Beach, California, United States
Brian Biesman, M.D
Nashville, Tennessee, United States
Start Date
February 23, 2023
Primary Completion Date
June 24, 2023
Completion Date
June 24, 2023
Last Updated
November 13, 2024
Lead Sponsor
Levation Pharma, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions